- Home
- PAPL vs RSLS Comparison
PAPL vs RSLS Comparison
Compare PAPL & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAPL
- RSLS
- Stock Information
- Founded
- PAPL 2015
- RSLS 2002
- Country
- PAPL Canada
- RSLS United States
- Employees
- PAPL N/A
- RSLS N/A
- Industry
- PAPL Finance: Consumer Services
- RSLS Medical/Dental Instruments
- Sector
- PAPL Finance
- RSLS Health Care
- Exchange
- PAPL Nasdaq
- RSLS Nasdaq
- Market Cap
- PAPL 2.8M
- RSLS 4.5M
- IPO Year
- PAPL 2023
- RSLS 2007
- Fundamental
- Price
- PAPL $0.11
- RSLS $0.33
- Analyst Decision
- PAPL Strong Buy
- RSLS Hold
- Analyst Count
- PAPL 2
- RSLS 1
- Target Price
- PAPL $5.25
- RSLS N/A
- AVG Volume (30 Days)
- PAPL 2.7M
- RSLS 26.4M
- Earning Date
- PAPL 04-14-2025
- RSLS 05-19-2025
- Dividend Yield
- PAPL N/A
- RSLS N/A
- EPS Growth
- PAPL N/A
- RSLS N/A
- EPS
- PAPL N/A
- RSLS N/A
- Revenue
- PAPL $2,848,365.00
- RSLS $8,006,000.00
- Revenue This Year
- PAPL $7.18
- RSLS $52.80
- Revenue Next Year
- PAPL $25.02
- RSLS N/A
- P/E Ratio
- PAPL N/A
- RSLS N/A
- Revenue Growth
- PAPL 13.01
- RSLS N/A
- 52 Week Low
- PAPL $0.11
- RSLS $0.30
- 52 Week High
- PAPL $2.10
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- PAPL 18.51
- RSLS 41.66
- Support Level
- PAPL $0.11
- RSLS $0.33
- Resistance Level
- PAPL $0.15
- RSLS $0.47
- Average True Range (ATR)
- PAPL 0.03
- RSLS 0.05
- MACD
- PAPL -0.01
- RSLS 0.03
- Stochastic Oscillator
- PAPL 5.21
- RSLS 3.47
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.